Macquarie Group’s Immunogen Inc IMGN Stock Holding History

Macquarie Group’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,834	Closed	-$25K	–	2188
2022 Q3	$25K	Sell	1,834 -3,361	-65%	-$17.7K	﹤0.01%	2145
2022 Q2	$23K	Hold	5,195	–	–	﹤0.01%	2269
2022 Q1	$25	Hold	5,195	–	–	﹤0.01%	2339
2021 Q4	$39K	Hold	5,195	–	–	﹤0.01%	2239
2021 Q3	$29K	Hold	5,195	–	–	﹤0.01%	2375
2021 Q2	$34K	Hold	5,195	–	–	﹤0.01%	2244
2021 Q1	$42K	Sell	5,195 -1,593	-23%	-$13K	﹤0.01%	2121
2020 Q4	$44K	Hold	6,788	–	–	﹤0.01%	2073
2020 Q3	$24K	Hold	6,788	–	–	﹤0.01%	2132
2020 Q2	$31K	Buy	+6,788	New	+$28.9K	﹤0.01%	2050
2019 Q4	–	Sell	-212	Closed	-$1K	–	1975
2019 Q3	$1K	Buy	+212	New	+$563	﹤0.01%	1874
2019 Q2	–	Sell	-350,000	Closed	-$949K	–	1888
2019 Q1	$949K	Sell	350,000 -300,000	-46%	-$1.3M	﹤0.01%	1205
2018 Q4	$3.12M	Hold	650,000	–	–	0.01%	858
2018 Q3	$6.16M	Sell	650,000 -483,000	-43%	-$4.64M	0.01%	738
2018 Q2	$11M	Buy	1,133,000 +3,000	+0.3%	+$31.6K	0.02%	616
2018 Q1	$11.9M	Sell	1,130,000 -17,300	-2%	-$171K	0.02%	582
2017 Q4	$7.35M	Buy	1,147,300 +297,300	+35%	+$1.83M	0.01%	705
2017 Q3	$6.5M	Hold	850,000	–	–	0.01%	696
2017 Q2	$6.04M	Buy	850,000 +150,000	+21%	+$686K	0.01%	699
2017 Q1	$2.71M	Hold	700,000	–	–	﹤0.01%	895
2016 Q4	$1.43M	Sell	700,000 -230,000	-25%	-$462K	﹤0.01%	1066
2016 Q3	$2.49M	Sell	930,000 -930,000	-50%	-$2.7M	﹤0.01%	897
2016 Q2	$5.73M	Buy	1,860,000 +1,380,000	+288%	+$8.65M	0.01%	846
2016 Q1	$4.09M	Buy	480,000 +50,000	+12%	+$423K	0.01%	761
2015 Q4	$5.83M	Hold	430,000	–	–	0.01%	672
2015 Q3	$4.13M	Hold	430,000	–	–	0.01%	777
2015 Q2	$6.18M	Hold	430,000	–	–	0.01%	687
2015 Q1	$3.85M	Buy	430,000 +140,000	+48%	+$1.01M	0.01%	826
2014 Q4	$1.77M	Hold	290,000	–	–	﹤0.01%	1049
2014 Q3	$3.07M	Buy	290,000 +25,000	+9%	+$283K	0.01%	861
2014 Q2	$3.14M	Sell	265,000 -3,077	-1%	-$38.6K	0.01%	869
2014 Q1	$4M	Buy	268,077 +203,847	+317%	+$3.21M	0.01%	741
2013 Q4	$942K	Buy	64,230 +5,490	+9%	+$84.4K	﹤0.01%	1165
2013 Q3	$1M	Buy	58,740 +2,950	+5%	+$51.9K	﹤0.01%	1174
2013 Q2	$926K	Buy	+55,790	New	+$904K	﹤0.01%	1171

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Macquarie Group's IMGN Position: Q4 2022 in Review

Macquarie Group sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 1,834 shares — an estimated $25K sold.

Macquarie Group first reported a position in IMGN in Q2 2013 and held it in 35 quarters. The position peaked at $11.9M in Q1 2018. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

Macquarie Group reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
Macquarie Group sold 1,834 Immunogen Inc shares in Q4 2022, an estimated $25K.
Macquarie Group first reported a position in Immunogen Inc in Q2 2013 and held it in 35 quarters.
Macquarie Group's Immunogen Inc position peaked at $11.9M in Q1 2018.
204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on Macquarie Group's 13F filing for Q4 2022, filed 21 Feb 2023.